drugset / Trial / NCT06077331
A Study to Evaluate Efficacy and Safety of HS-10374 for Moderate to Severe Plaque Psoriasis
RandomizedParallel-groupDouble-blindTreatment
Summary
This study has been designed to explore the clinical efficacy and safety of HS-10374 in the treatment of moderate to severe plaque psoriasis. Additionally, this study is to find the optimal dosing for the future clinical development of HS-10374.
Timeline
- Start
- 2023-09-28
- Primary completion
- 2024-07-31
- Completion
- 2024-08-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HS-10374 | Unknown | 1 mg | Oral |
| Subject | HS-10374 | Unknown | 5 mg | Oral |